WisdomTree BioRevolution Fund (BATS:WDNA) Stock Price Down 0.3% – Here’s Why

Posted by ABMN Staff on Jul 15th, 2026

WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s stock price fell 0.3% on Tuesday . The company traded as low as $20.20 and last traded at $20.20. Approximately 59 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 924 shares. The stock had previously closed at $20.27.

WisdomTree BioRevolution Fund Trading Down 0.3%

The firm has a market cap of $3.03 million, a P/E ratio of 17.03 and a beta of 1.01. The firm’s 50 day moving average is $18.79 and its two-hundred day moving average is $18.11.

Hedge Funds Weigh In On WisdomTree BioRevolution Fund

A hedge fund recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its position in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,864 shares of the company’s stock after buying an additional 5,306 shares during the period. Jane Street Group LLC owned approximately 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent quarter.

About WisdomTree BioRevolution Fund

(Get Free Report)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.